MarketWatch: Health Round-up


Pages: 54

Publisher: Datamonitor

Date Published: January 2006

Format: PDF

Price: $400

Add to Cart

Overview

Datamonitor’s MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month’s major issues and events in R&D, regulatory and licensing in the Healthcare industry.

Table of Contents

In this month’s MarketWatch…


Pharmaceutical Company Round-up

Page 3

Cancer Update

Page 5 – News Round-up

Page 8 – Opinion: Schering AG: hoping for a triple trial triumph…

Page 8 – Opinion: ZymoGenetics: early hope for late-stage disease…

Page 9 – Opinion: GlaxoSmithKline: Zofran sales set for off-Par performance…

Page 10 – Opinion: Sanofi-Aventis: Taxotere sales set for modest boost…

Page 11 – Opinion: Prostate cancer: awaiting innovation…

Page 12 – Opinion: Millennium: Velcade set for cancer consolidation…

Page 13 – Feature Analysis: Chronic leukemias: different forms, different problems, different solutions…

Cardiovascular Update

Page 15 – News Round-up

CNS Update

Page 17 – News Round-up

Page 19 – Opinion: GSK: Avandia may help Alzheimer’s patients…

Page 19 – Opinion: Sepracor: pain-free sleep…

Page 20 – Opinion: Big pharma: SSRI risks could limit depression market…

Page 21 – Opinion: Noven/Shire: a patch in the balance…

Page 22 – Opinion: Boehringer Ingelheim/Biolipox: a pain-free partnership…

IDI Update

Page 23 – News Round-up

Page 26 – Opinion: Sepracor: gasping for gold…

Page 27 – Opinion: Bristol-Myers Squibb: $1 billion cost savings by 2008…

Page 27 – Opinion: World COPD Day: a good start but greater awareness needed…

Page 28 – Opinion: Merck & Co: restructuring to safeguard future…

Page 30 – Feature Analysis: GlaxoSmithKline winded by FDA label clampdown…

Page 31 – Feature Analysis: Osteoporosis: compliance is the key…

Infectious Diseases Update

Page 33 – News Round-up

Page 35 – Opinion: Cubist: more good news for superbug drug…

Company Spotlight

Page 36 – Eli Lilly

Biotechnology Update

Page 43 – Biotech News Round-up

Company Spotlight

Page 46 – Vertex Pharmaceuticals

Index

Page 53 – Pharma companies

Page 53 – Biotech companies

Page 54 – Key drugs